Skip to main content
. 2022 Apr 11;18(6):337–352. doi: 10.1038/s41574-022-00655-w

Fig. 4. Chemical structures of current oral glucocorticoid and mineralocorticoid preparations used in the management of classic congenital adrenal hyperplasia.

Fig. 4

Chemical structures for short-acting, intermediate-acting and long-acting glucocorticoids and mineralocorticoids used for the management of classic congenital adrenal hyperplasia.